Document:

EX-10.10

 Exhibit 10.10 

SUPPLY AGREEMENT 
 This Supply Agreement
(“Agreement”) is made effective as of January 14, 2021 (“Effective Date”) between Sight Sciences, Inc., a Delaware corporation with its principal office and place of business at 4040 Campbell Avenue, Suite 100,
Menlo Park, California 94025 (“Buyer”), and Peter’s Technology (Suzhou) CO., LTD., a Suzhou, Jiangsu Province corporation, with its principal place of business at No. 99 Jishi East Road, Wu Jiang District, Suzhou City,
Jiangsu Province, P.R. China 215200 (“Supplier”). 
 BACKGROUND 

 

	A.	 Supplier manufactures and/or supplies the Products listed in Exhibit A, and 

 

	B.	 Buyer designs, manufactures and sells medical devices and wishes to purchase the Products for use in its
business. 

 TERMS OF AGREEMENT 

For good, valuable and sufficient consideration, Buyer and Supplier agree as follows: 

 

	1.	 DEFINITIONS 

  

	1.1	 In addition to capitalized terms defined elsewhere in this Agreement, when used in this Agreement the following
capitalized terms have the meanings indicated below: 

 “Agreement” means this Agreement, all Exhibits and
any purchase orders placed under this Agreement. 
 “Applicable Law” means any law, statute, code, rule, regulation,
published interpretation, ordinance, directive, regulatory bulletin or guidance, regulatory examination or order, treaty, judgment, order, decree or injunction of any Governmental Authority that is applicable to or binding in the jurisdiction and/or
situation in which the term is used. 
 “Buyer Intellectual Property” means Intellectual Property that is owned or
controlled by Buyer as of the Effective Date or comes into Buyer’s ownership, possession or control after the Effective Date, including, without limitation, the Buyer Confidential Information, Developed Intellectual Property and the
Specifications (as well as the Intellectual Property embodied in the Equipment and Tools). 
 “cGMP” shall mean Good
Manufacturing Practices as promulgated under the FD&C Act (including Quality System Regulation for medical devices, as defined in 21 C.F.R. Part 820), as well as any other applicable regulations, policies or guidelines, as then in effect, of the
FDA and other United States or foreign governmental or regulatory agencies with jurisdiction over the manufacture, use, distribution or sale of the Products. 

“Developed Intellectual Property” means Intellectual Property that comes into existence (as measured from October 1,
2020) in the course of or relating to Supplier’s performance of its obligations under this Agreement that is derived from Buyer’s Intellectual Property or its Confidential Information. Developed Intellectual Property shall
constitute Buyer Intellectual Property. 
 “FDA” means the United States Food and Drug Administration, and any
successor agency having substantially the same functions. 
 “FD&C Act” shall mean the U.S. Federal Food,
Drug & Cosmetic Act, as in effect from time to time. 

  
 Page 1 of 21 

 “Force Majeure” means riots, war, terrorism, invasion, acts of God,
pandemic, fire, explosion, floods, orders of a Governmental Authority or any other cause beyond the reasonable control and without the fault or negligence of a party that prevent such party’s performance under this Agreement. 

“Governmental Authority” means any government, state or political subdivision thereof and any entity exercising executive,
legislative, judicial, regulatory or administrative functions of or pertaining to government, including federal, state or local entities in the jurisdiction and/or situation in which the term is used. 

“Import/Export Laws” means all laws, treaties, governmental orders and regulations of the countries from which a
Product is exported and to which a Product is imported, including rules regarding classification, marking, packaging, and payments of tariffs and duties. 

“Intellectual Property” means ideas, design specifications, inventions, proprietary information, trade secrets,
research and development data, manufacturing processes/procedures, software, works of authorship, improvements, or suggestions, whether or not patentable or copyrightable, conceived, created, adapted, or reduced to practice by or for a party,
whether made alone or in conjunction with others. 
 “Latent Defect” shall mean a defect that causes a Product to not
conform to Buyer’s purchase order or Specifications, or to the Product Warranties, which defect is not discoverable upon reasonable physical inspection. 

“Manufacture” and “Manufacturing” means all steps, processes and activities necessary to
produce Product(s), including without limitation, the design, manufacturing, processing, quality control testing, release and storage of Product(s) in accordance with the terms and conditions of this Agreement. 

“Personnel” means Supplier’s employees, agents, contractors, consultants and subcontractors whose services are used in
accordance with the terms of this Agreement to perform its obligations under this Agreement. 
 “Product(s)” means the goods
purchased by Buyer from or through Supplier listed on Exhibit A, as the same may be supplemented or revised by the parties. 

“Product Warranties” shall mean the representations and warranties made by Supplier in Sections 8.1 and 8.2 of this Agreement

 “Publicly Available Software” means (a) any software that contains, or is derived in any manner (in whole or in
part) from, any software that is distributed as free software, open source software or similar licensing or distribution models; and (b) any software that requires as a condition of use, modification, and/or distribution of such software that
such software or other software incorporated into, derived from, or distributed with such software (i) be disclosed or distributed in source code from, (ii) be licensed for the purpose of making derivative works, or (iii) be
redistributable at no charge. 
 “Quality Requirements” means, with respect to a Product, the requirements set forth in this
Agreement and in any written quality agreement or other written standards provided by Buyer covering such Product and agreed between Buyer and Supplier. 

“Restricted Party Lists” means (i) any of the restricted party lists maintained by the U.S. Government,
including the Specially Designated Nationals List and Foreign Sanctions Evaders List administered by the U.S. Department of Treasury’s Office of Foreign Assets Controls (OFAC), the Denied Parties List, Unverified List or Entity List maintained
by the U.S. Department of Commerce Bureau of Industry and Security, and the List of Statutorily Debarred Parties maintained by the U.S. State Department’s Directorate of Defense Trade Controls, (ii) the consolidated list of asset freeze
targets designated by the United Nations, European Union, and United Kingdom, and any other applicable jurisdictions, and (iii) any other restricted party lists maintained by any Governmental Authority. 

  
 Page 2 of 21 

 “Specifications” means all applicable specifications and protocols relative
to the design, physical characteristics, function, performance, Manufacture, packaging and quality of the Products listed on Exhibit A or as otherwise communicated in writing by Buyer, including, without limitation, the specifications set
forth on attached Exhibit B. 
 “Supplier Facility” means the manufacturing facility where Supplier will
Manufacture a Product, which facility is located as specified in the purchase order placed thereunder, quality agreement, or such other facility designated by Supplier and accepted by Buyer in a separate writing by the parties. 

“Supplier Intellectual Property” means Intellectual Property that is owned by or licensed to (with the right to grant
sublicenses) Supplier and exists on the Effective Date or is thereafter developed by or licensed to Supplier independent of Buyer Intellectual Property (and excluding in all instances the Buyer Intellectual Property). 

“Trade Control Laws” means all applicable export control and economic sanctions laws and regulations of the
United States, the European Union and all other applicable jurisdictions, including but not limited to the U.S. Department of Commerce Bureau of Industry and Security’s Export Administration Regulations, 15 C.F.R.
730-774, the economic sanctions programs administered by the U.S. Department of Treasury’s Office of Foreign Assets Controls (“OFAC”), as set forth in 31 C.F.R.
500-598 and certain executive orders, EU Regulation 428/2009 imposing controls on exports of dual-use items, OJ L 134, 29.5.2009, p. 1, and economic sanctions
regulations implemented by the European Council, and any export controls or economic sanctions measures implemented by EU Member States. 
  

	2.	 PRODUCT ORDERING AND SALE 

 

	2.1	 Sale of Products. Supplier shall sell and supply the Products to Buyer at the prices established
pursuant to Section 3. To the extent a Product includes embedded software, the term “sell” means, with respect to such software, the grant of a non-exclusive, fully-paid, perpetual, worldwide,
sublicensable (through multiple tiers of sublicensees), assignable license for Buyer to market, sell, distribute and otherwise use and exploit, and to allow Buyer’s customers and end-users to use, such
software in connection with the Product. 

  

	2.2	 Other Sales. Supplier will not, during the term of this Agreement, provide any Product to any third
party without the prior written approval of Buyer. This obligation shall survive the expiration or termination of the Agreement for a period of one (1) year and indefinitely with respect to Products and products that utilize, are derived from
or embody any Buyer Intellectual Property, including, without limitation, any Specifications. The obligations in this Section 2.2 shall not apply with respect to products that were developed by Supplier or a third party without the use of Buyer
Intellectual Property. 

  

	2.3	 Firm Order and Forecasting. Buyer will submit to Supplier the orders and forecasts below to assist
Supplier in anticipating Buyer’s Product needs for twelve-months into the future. 

  

	 	2.3.1	 Firm Orders. An order to which Buyer is bound will be referred to in this Section 2.3 as a
“Firm Order.” Firm Orders may be rescheduled only by mutual agreement or cancelled in accordance with Section 2.4.3 (Termination of Orders). Buyer shall provide Supplier with an initial Firm Order for Products for three
(3) months. 

  
 Page 3 of 21 

	 	2.3.2	 Product Order Process. Products will be ordered via standard Buyer purchase orders, which shall, at a
minimum, identify the Products and set forth the corresponding quantities, confirmation of price, delivery dates, shipping instructions and shipping addresses. Buyer may submit purchase orders via mail, fax, email or, if mutually agreed by the
parties, electronic data interchange (EDI). Orders will be deemed accepted upon receipt. 

  

	 	2.3.3	 Initial Forecast. Buyer shall also provide Supplier with a written,
non-binding, Product purchase forecast in monthly increments consisting of a forecast for the nine (9) months after the end of the Firm Order (“Planning Period”). The above forecasts for
the Planning Period are non-binding, and Buyer may change them at any time by providing a new written forecast to Supplier. 

 

	 	2.3.4	 Subsequent Forecasts and Orders. At the start of each calendar month, the Products forecast for the
first month of the Planning Period forecast automatically become part of an additional month Firm Order at the end of the then-current Firm Order, so that a rolling Firm Order of three (3) months is always maintained. Within the first seven
(7) Business Days after the start of each calendar month, Buyer shall deliver a new Planning Period forecast, revised so that forecasts for nine (9) month periods are always maintained. 

 

	2.4	 Order Terms. 

  

	 	2.4.1	 Surge Capacity. Supplier shall satisfy all Buyer orders that are submitted in a manner consistent with
the terms of this Agreement. Supplier shall have the capacity to satisfy at least a thirty percent (30%) increase over the forecasted amount; provided, however, a reasonable ninety (90) days advance written notice relating to such increase is
provided to Supplier by Buyer. 

  

	 	2.4.2	 Allocation. Supplier will provide Buyer one hundred percent (100%) of the quantities of Products
forecasted and will use reasonable best efforts to provide all other quantities ordered. If Supplier cannot deliver all Products when due, Supplier shall give Buyer’s purchase orders first priority to capacity for production and delivery of
Products other than only as to capacity necessary to fulfill mandatory government contract commitments. In addition, and not in lieu of the foregoing, if Supplier fails to deliver Product on a timely basis and to cure such breach within thirty
(30) days after Buyer’s written notice and Buyer is required to procure such Product from another supplier, Supplier shall pay for any reasonable increase over the relevant price on Exhibit A or the purchase order submitted
thereunder. In any event, if Supplier cannot supply the full amount of the order within the time requested and cannot cure the breach within the time limit specified in this Agreement, Buyer may terminate any or all of such order.

  

	 	2.4.3	 Termination of Orders. Buyer may terminate in whole or in part an order or orders by written notice to
Supplier (i) for safety or regulatory reasons caused by Supplier, (ii) if, as a result of a Force Majeure event, Supplier remains unable to deliver such Product for more than ninety (90) days, or (iii) if Supplier fails to cure a
material breach with respect to the order within thirty (30) days after written notice. 

  

	2.5	 Delivery. 

  

	 	2.5.1	 Shipping Terms. Unless otherwise specified in an applicable order, delivery of Products will be Ex Works
(Incoterms, as then in effect) Supplier’s Facility, and title and risk of loss will pass at that point. 

  

	 	2.5.2	 Shipment. Shipment of the Products will be freight collect via Buyer-designated mode and carrier.
Supplier will ship Products using the method of shipment and carrier specified on Buyer’s purchase order, or if none is specified, via Buyer’s preferred carrier such that the Products will be delivered by the requested delivery dates and
to the locations specified in 

  
 Page 4 of 21 

	 	
Buyer’s purchase orders. Supplier shall use the Buyer account number, if available, with such carriers when shipping Products. Unless the carrier is specified on the purchase order,
Supplier shall verify with Buyer that the carrier is a preferred Buyer carrier before shipping Products. Supplier shall provide Buyer electronic notice of each Product shipment on the shipment/delivery date. Supplier shall include a packing list,
certificate of conformance and lot history record (in addition to such other equivalent documentation as may be agreed to by the parties) in each shipment. Pursuant to this documentation, Seller shall certify that the Products contained in each such
shipment comply in all respects with the Specifications and applicable Quality Requirements. 

  

	 	2.5.3	 Delays. Supplier shall promptly notify Buyer of any actual or prospective delay in delivery, and
Supplier shall obtain Buyer’s approval prior to making any partial deliveries. If the delivery of Product is delayed through the fault of Supplier and Supplier has failed to cure such delay within any applicable cure periods as specified in
this Agreement, Buyer may, at its option, in addition to its other rights and remedies under this Agreement, terminate or reschedule the order in whole or in part without liability or require Supplier to deliver Product by means of commercially
reasonable premium transport agreed by the parties, at Supplier’s cost (of which Supplier will pay for the difference between the premium transport costs and the Buyer’s original shipping costs) or take a two percent (2%) discount on all
orders delayed more than thirty (30) days. Product shall not be delivered early without Buyer’s prior written consent. In the event of a rescheduled or cancelled order per this section, Buyer still shall be considered to have met all firm
or other commitments set forth in Section 2.3 as to the period in which such orders were originally scheduled and any rescheduled amount shall further count toward any firm commitment for the period in which it is actually delivered.

  

	 	2.5.4	 Acceptance and Rejection. Buyer may reject any Product that does not conform to the Specifications or to
the Product Warranties. To reject a Product, Buyer must give written notice of rejection to Supplier within sixty (60) days after receipt of such Product or, in the case of a Latent Defect, within sixty (60) days after Buyer becomes aware
of such Latent Defect, which notice shall specify Buyer’s reason for rejection. If no such notice of rejection is received within sixty (60) days after receipt of the Product or, in the case of a Latent Defect, within sixty (60) days
after Buyer becomes aware of such Latent Defect, Buyer shall be deemed to have accepted such shipment of Products, provided that, notwithstanding any acceptance or deemed acceptance of Products, the Product Warranties shall continue to cover the
Supplier Product. Any Product rejected by Buyer will be returned to Supplier at Supplier’s request and expense within sixty (60) days after receipt of such Product or, in the case of a Latent Defect, within sixty (60) days after Buyer
becomes aware of such Latent Defect. Whether or not Supplier accepts Buyer’s basis for rejection, Supplier will supply replacement Product within thirty (30) days of notice of rejection at no additional cost. Within thirty (30) days
after receiving any notice of rejection from Buyer, Supplier will respond stating whether (a) it accepts the rejection or (b) it disputes the rejection, in which case the parties will refer such dispute to a mutually acceptable independent
third party with the appropriate expertise to assess the conformity or non-conformity of the rejected Product to the Product Warranties. Such independent third party shall examine or test the applicable
Products and shall determine whether such Products conformed or did not conform to the Product Warranties. The parties agree that such third party’s determination shall be final and binding upon the parties. The party against whom the
independent third party rules shall bear the costs of testing by such independent third party, and if such third party determines that Buyer’s rejection of the Products was incorrect, Buyer will purchase and pay for both the initially rejected
Products and the replacement Products. 

  
 Page 5 of 21 

	3.	 PRICING AND PAYMENT  

 

	3.1	 Prices. 

  

	 	3.1.1	 Product Pricing. Product prices shall be calculated as provided in Exhibit A and will not
increase for an initial period of one (1) year. Thereafter such prices will be subject to review and good faith negotiation at the request of either party, not more than once per year. Mutually agreed prices will remain in effect until changed
on the basis specified in this Section 3.1. 

  

	 	3.1.2	 Cost Reductions. Supplier shall use commercially reasonable best efforts to reduce the aggregate cost of
Products. Cost reduction efforts shall not compromise quality or reliability, and Supplier shall comply with the Quality Requirements with respect to design and process changes. Supplier shall give Buyer notice of the cost reductions as soon as
practicable, but in any event within thirty (30) days of the accomplished reduction. Thereafter, all invoices shall reflect such reduced pricing. 

  

	3.2	 Payment Terms. Payment terms shall be 1% discount, fifteen (15) days, net thirty
(30) after the date of invoice. Invoicing requirements, if any, will be as specified in a mutually agreed electronic format, or if there is no such format, in the applicable Purchase Order. Following request by Buyer, Supplier shall submit
invoices electronically via a means specified by Buyer. 

  

	4.	 PRODUCTION AND QUALITY 

 

	4.1	 Production.  

  

	 	4.1.1	 Product Manufacturing. Supplier shall Manufacture, package and label the Products in strict accordance
with the applicable Specifications and the Quality Requirements, including, without limitation, cGMP and the FD&C Act. Products shall be Manufactured only at the Supplier Facility unless Buyer, in its sole discretion, provides advance written
approval of an alternative facility. In the event Buyer notifies Supplier of any new manufacturing requirements or specifications required by Buyer, the FDA or any other regulatory agency, or of any other new legal requirements, the parties shall
promptly confer with each other with respect to the best means to comply with such requirements and allocate any costs of implementing such changes on an equitable basis. Without the prior written approval of Buyer, or as otherwise set forth in a
separate quality agreement between Supplier and Buyer, (i) Supplier shall not implement any change in the manufacturing process or the equipment, facility or materials used in the manufacture of the Product; and (ii) Supplier shall not
source any Product components or raw materials from any supplier unless such supplier has been validated and approved in advance by Buyer in its sole discretion. Supplier shall comply with the applicable Quality Requirements when making any changes
to the Specifications, design, materials, production processes or production testing. Upon request, Supplier will permit representatives of Buyer to observe such manufacture and to have access to any relevant records in connection with such
Manufacture. Upon Buyer’s written request, Supplier shall supply Buyer with copies of Supplier’s Manufacturing records for the purposes of assuring product quality and compliance with cGMP and other applicable requirements. Supplier
represents and warrants to Buyer that it has, and will maintain during the term of the Agreement, all government permits, including, without limitation, health, safety and environmental permits, necessary for the conduct of the actions and
procedures that it undertakes pursuant to this Agreement. 

  

	 	4.1.2	 Specifications; Testing. Supplier shall perform Manufacturing process verification and validation
of the Products, as well quality control testing and quality oversight on Products to be delivered to Buyer or its designee hereunder, in accordance with the Specifications and cGMP. Products supplied hereunder will conform to the Specifications.
The parties 

  
 Page 6 of 21 

	 	
agree that, should Buyer wish to implement any amendment to the Specifications, Buyer shall provide written notice thereof to Supplier for Supplier’s review and approval, which approval
shall not be unreasonably withheld, delayed or conditioned. The parties acknowledge that the Specifications may need to be refined and modified as the parties gain experience with the manufacture, testing and use of the Products. Accordingly, Buyer
and Supplier agree to negotiate in good faith to modify the Specifications from time to time as the parties’ experience with the manufacture, testing and use of the Products warrants. Supplier further agrees that it will facilitate changes to
the Specifications that are necessary or appropriate in light of FDA or other regulatory requirements as updated by Buyer from time to time. The parties agree to allocate on an equitable basis any special costs of developing and implementing revised
procedures. 

  

	 	4.1.3	 Regulatory Support. Except as otherwise expressly set forth herein, Buyer shall be responsible
for all filings necessary for approval to market the Products. Supplier agrees to promptly provide to Buyer such information relating to the Products or the manufacture thereof as may be necessary or useful in connection therewith

  

	 	4.1.4	 Production Indemnity. Buyer will not be liable for, and Supplier assumes responsibility for and will
defend, indemnify and save harmless Buyer from, all personal injury and property damages that occur during Manufacturing of a Product or for claims based on violations of Applicable Laws or (including those applicable to employee or environmental
protection) in connection with such production (e.g., a claim based on Supplier’s violations of environmental standards or standards dealing with providing a safe place to work or the maintenance of hazardous materials) and in connection with
the breach of any warranty herein. 

  

	4.2	 Risk Management. 

 

	 	4.2.1	 Disaster Recovery. Supplier shall practice ongoing business continuity planning to minimize disruptions
to its ability to fulfill its obligations under this Agreement. Supplier shall maintain a written disaster recovery plan and shall cooperate with Buyer’s efforts to periodically review Supplier’s plan and planning. Supplier shall notify
Buyer within twenty-four (24) hours if, in accordance with the disaster recovery plan, Supplier plans to move the Manufacture of any Product to a different Supplier Facility. 

 

	4.3	 Quality. Supplier shall comply with the Quality Requirements in its Manufacture of Products.
Supplier shall also comply with Applicable Laws, applicable standards of the International Standards Organization (ISO) and all other quality standards and quality assurance plans referenced in the Specifications and any separate quality
agreement between the parties. Each set of applicable Quality Requirements for a particular Product survive until such Quality Requirements are replaced with other Quality Requirements, or such Products are no longer provided by Supplier under this
Agreement or otherwise. 

  

	4.4	 Use and Return of Buyer Property. Any molds, equipment, tooling and related materials that Buyer
furnishes to Supplier or Supplier develops or purchases at Buyer’s expense, if any (collectively, “Equipment and Tools”), shall be used only in the performance of work for Buyer and shall remain the property of Buyer. Upon
Buyer’s request, Supplier shall return all Equipment and Tools in good repair, normal wear and tear excepted, to Buyer at Buyer’s direction and expense. Supplier assumes risk of loss and damage and shall calibrate, maintain, and repair the
Equipment and Tools in its possession or under its control at its expense, normal wear and tear excepted. Supplier shall notify Buyer promptly whenever any Equipment and Tools are damaged or are in need of replacement, which will be done at
Supplier’s expense if such damage or replacement is caused by Supplier’s fault. Equipment and Tools shall be marked or otherwise adequately identified by Supplier as property of Buyer for use only under this Agreement and shall be safely
stored. 

  
 Page 7 of 21 

	 	
Supplier waives any right it may have in law or equity to withhold Buyer’s property. Supplier shall remain responsible for any and all claims or injuries related to the usage and storage of
the equipment in its facility. Supplier shall give Buyer access to relevant Supplier facilities, books and records during normal business hours to audit Supplier’s compliance with this section so long as Buyer gives Supplier at least ten
(10) days’ advance written notice. 

  

	4.5	 Subcontracting. Supplier may not subcontract any of its obligations under the Agreement without
Buyer’s prior written consent. If Buyer consents to such an arrangement, any subcontracting will be subject to the following terms:  

  

	 	4.5.1	 The subcontracting must be under a written agreement which (i) obligates the subcontractor to comply with
all relevant terms and conditions of this Agreement as though it were Supplier, (ii) names Buyer as a third party beneficiary with the right to enforce the rights of Supplier under such subcontract agreement, and (iii) authorizes
Supplier to disclose the terms of the subcontract agreement to Buyer. Supplier shall provide Buyer with a copy of a subcontract agreement promptly after Buyer’s request. 

 

	 	4.5.2	 Supplier shall be responsible for all acts and omissions of its subcontractor and guarantees the
subcontractor’s performance. 

  

	4.6	 Discontinuation. Supplier shall not discontinue a Product during the Initial Term (defined in 10.1).
Following the Initial Term, if Supplier desires to stop making a Product, Supplier shall give Buyer written notice (“Discontinuation Notice”) at least twelve (12) months before the date on which Supplier will stop making a
Product (“Discontinuation Date”). In such case, Supplier will provide a backup plan for Buyer to mitigate risk to Buyer. Buyer is not obligated to accept such plan. So long as Buyer places orders at least three (3) months
before the planned Discontinuation Date, Supplier shall accept last time buy orders for the discontinued Product(s) at the prices in effect as of the date of the Discontinuation Notice; provided, however, that Supplier shall pass on to
Buyer any savings that result due to the increased volumes ordered. Unless the parties agree otherwise in the order documentation, delivery of the Product in a last time buy order shall be in accordance with the terms of the applicable order(s)
delivered by Buyer, and in any event within one (1) year of the Discontinuation Date. If Supplier fails to comply with the requirements set forth in this Section 4.6, Buyer may invoke the license and technology transfer specified under
Section 7.3 (Failure to Supply License) for discontinued Products by written notice to Supplier given no more than three (3) months after receipt of the Discontinuation Notice. 

 

	5.	 LEGAL AND REGULATORY COMPLIANCE 

 

	5.1	 Compliance with Applicable Laws. Each party shall comply with all Applicable Laws in the performance of
its obligations under this Agreement, and each party represents and warrants that it shall have obtained all required licenses and permits to engage in the activities necessary to perform its obligations under this Agreement. 

 

	5.2	 Import/Export and Trade Control Compliance. 

5.2.1    Supplier shall comply with applicable Import/Export Laws and Trade Control Laws regarding the shipping, purchase,
procurement, import, export, and any other transfer of all Products and any parts, components or materials incorporated into all Products. For purposes of Sections 5.2.1 and 5.2.2, Products includes product-associated technology and technical data,
whether provided by Buyer or Supplier, and the documents related to that technology and data. Supplier represents and warrants that all provision of Products by Supplier under this Agreement and all payments for such activities comply with the
Import/Export Laws and Trade Control Laws, including the terms of any relevant authorizations issued by any U.S. or non-U.S. Governmental Authority. Supplier shall immediately notify Buyer if Supplier’s
export privileges are denied, suspended or revoked in whole or in part by any U.S. or non-U.S. Governmental Authority. 

  
 Page 8 of 21 

 5.2.2    Supplier hereby acknowledges and confirms that, unless
specifically authorized in this Agreement and under applicable Import/Export Laws or Trade Control Laws, it will not sell, ship, export, re-export, re-transfer or divert
Products that are sold or otherwise provided hereunder (including samples), directly or indirectly through third parties or otherwise, to any company or individual on the Restricted Party Lists or to or through persons that are, or who are located,
organized, or resident in a country or territory that is (or whose government currently is), the target of sanctions imposed by any U.S. Governmental Authority. 

5.2.3    Supplier understands that Buyer’s participation, directly or indirectly, in any business under terms that
would support or facilitate a boycott against Israel or any other boycott not recognized by the U.S. is prohibited. Notwithstanding any other provision of this Agreement, neither Buyer nor Supplier shall be required to take, or to refrain from
taking, any action where to do so would be inconsistent with or penalized under Applicable Law, including without limitation the anti-boycott laws administered by the U.S. Commerce and Treasury Departments. 

 

	5.3	 Conflict Minerals. For Products delivered to Buyer under this Agreement, Supplier shall provide Buyer,
at no additional cost, with assistance and sufficient documentation, as reasonably determined by Buyer, to enable Buyer to comply with its obligations, as applicable, under Section 1502 of the Dodd-Frank Wall Street Reform and Consumer
Protection Act (the “Reform Act”) and the rules and regulations promulgated thereunder relating to Conflict Minerals as defined in the Reform Act, and other similar laws or regulations. Such assistance and documentation may include but
shall not be limited to (i) completing and submitting questionnaires or templates relating to the origin of products, materials, parts, components, metals or any Conflict Minerals contained in the Products (collectively, “Surveys”)
within the deadline requested by Buyer; (ii) promptly responding to Buyer’s questions or request for additional information with respect to Supplier’s Survey; and (iii) to the extent the Products contain Conflict Minerals,
using diligent efforts to ensure traceability of those metals to the smelter level, including working with Supplier’s sub-suppliers to identify the origin of the Conflict Minerals. Supplier agrees to
maintain any documentation and data related to Supplier’s obligations under this Section, including any traceability data, for a period of five (5) years and agrees to provide Buyer with a copy of such documentation or data promptly upon
request. This obligation shall survive termination or expiration of this Agreement. From time to time, Buyer has the right to notify Supplier of changes to the requirements of this Section. 

 

	5.4	 Environmental Compliance. Supplier shall comply with the following terms and conditions for all Products
provided to Buyer: 

  

	 	5.4.1	 Supplier shall comply with all Environmental Regulations applicable to the Products. For the purposes of this
section, “Environmental Regulations” shall include any and all laws, regulations, directives, ordinances, orders and decrees of any kind, adopted or implemented in any country, state, region or jurisdiction, which govern, regulate or
restrict: (i) the use of hazardous substances; (ii) waste electrical and electronic equipment; (iii) batteries, accumulators and waste batteries and accumulators; (iv) packaging and packaging waste; and (v) the registration,
evaluation, authorization and restriction of chemicals. Supplier shall provide Buyer with assistance and sufficient documentation, as reasonably determined by Buyer, to enable Buyer to verify the materials used in the Products and that Products are
in full compliance with Environmental Regulations. 

  

	 	5.4.2	 During the term of this Agreement, in accordance with applicable Quality Requirements, Supplier shall promptly
notify Buyer of any changes in the Products’ design, technical specification, composition, components, substances or materials, or any permitted changes in a supplier of a component, substance or material, that may have an impact on the ongoing
compliance of the Products with Environmental Regulations. 

  
 Page 9 of 21 

	 	5.4.5	 Supplier certifies that it gathered the information required by this Agreement and that all information
submitted to Buyer in connection with this Agreement is accurate. Supplier acknowledges that Buyer will rely on this certification in determining the compliance of its products. Buyer acknowledges that Supplier may have relied on information
provided by others, and that Supplier may not have independently verified such information. However, in situations where Supplier has not independently verified information provided by others, Supplier agrees that, at a minimum, its suppliers have
provided certifications regarding their contributions to the Products, and those certifications are at least as comprehensive as the certification provided by Supplier. 

 

	5.5	 Compliance with Anti-Bribery Laws. Supplier will, and will ensure that it and its affiliates, and
any subcontractors and other third parties acting on its behalf in connection with this Agreement (collectively the “Supplier Parties”) will, comply with the United States Foreign Corrupt Practices Act, the U.K. Bribery Act, the Criminal
Law of the People’s Republic of China, and any analogous laws or regulations existing in any other country or region, as applicable (collectively, “Anti-Bribery Laws”), in connection with the performance of Supplier’s services
and obligations under this Agreement. None of Supplier or its affiliates, or, to Supplier’s knowledge, any other Supplier Party, has directly or indirectly made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments,
illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or otherwise taken any other action, in violation of the Anti-Bribery Laws. To Supplier’s knowledge, no Supplier Party is or has been the subject of
any investigation or inquiry by any governmental authority with respect to potential violations of Anti-Bribery Laws. In connection with this Agreement, Supplier will not make, offer, or authorize any payment, money, gift, fee, commission,
remuneration, or other thing of value to or for the benefit of any third party in order to influence an act or decision of the third party or for the purpose of assisting any party to this Agreement, or its affiliates, in obtaining or retaining
business or for the purpose of securing an improper advantage, or otherwise in violation of any Anti-Bribery Laws. Suppler shall cooperate with Buyer as necessary to enable Buyer to monitor and audit the Supplier Parties’ performance under
this Agreement for purposes of ensuring compliance with applicable Anti-Bribery Laws. 

  

	5.6	 Non-Discrimination and Human Trafficking. Buyer and Supplier
shall, to the extent they apply, abide by the requirements of 41 CFR §§ 60-1.4(a), 60-300.5(a) and 60-741.5(a). These
regulations prohibit discrimination against qualified individuals based on their status as protected veterans or individuals with disabilities, prohibit discrimination against all individuals based on their race, color, religion, sex, or national
origin and require affirmative action to employ and advance in employment individuals without regard to race, color, religion, sex, national origin, protected veteran status or disability. Supplier shall comply with all applicable labor laws, rules,
and regulations, including but not limited to, all laws forbidding the solicitation, facilitation, or any other use of slavery or human trafficking. 

  

	6.	 CONFIDENTIALITY AND PUBLICITY  

 

	6.1	 Confidential Information: The following is “Confidential Information” (collectively,
Buyer Confidential Information and Supplier Confidential Information, each as defined below) to be treated in accordance with the Agreement: 

  

	 	6.1.1	 “Buyer Confidential Information” means non-public
information relating to medical or diagnostic devices, components, accessories and attachments, including Specifications and drawings, Buyer Intellectual Property, business plans and other financial or marketing information disclosed to Supplier
during the Term. 

  
 Page 10 of 21 

	 	6.1.2	 “Supplier Confidential Information” means non-public
information of Supplier, including, but not limited to, Supplier Intellectual Property, that is disclosed to Buyer during the Term. 

  

	 	6.1.3	 In order for information to be considered Confidential Information hereunder it must be: 

 

	 	(i)	 if given in electronic or paper form, marked “confidential,” “proprietary” or the like at
the time of disclosure to the receiving party or within thirty (30) days of such disclosure; or 

  

	 	(ii)	 if given orally, identified as confidential in a written summary describing the Confidential Information
delivered to the receiving party within thirty (30) days of the disclosure; provided; however; 

 that in each
case of clauses (i) and (ii) above, information shall be considered the Confidential Information of the disclosing party if it is reasonably apparent from the nature of the information and circumstances of disclosure, that the information is of
a confidential or proprietary nature. 
  

	6.2	 Exclusions. Confidential Information does not include information that: 

 

	 	(i)	 is known to the receiving party prior to receipt thereof, as demonstrated by reliable evidence;

  

	 	(ii)	 is disclosed to the receiving party, without restriction or following expiration of a restriction, by a third
party; 

  

	 	(iii)	 is or becomes public knowledge, by publication or otherwise, through no fault of the receiving party; or

  

	 	(iv)	 is independently developed by the receiving party, as demonstrated by reliable evidence and without using
Confidential Information of the disclosing party. 

  

	6.3	 Obligations. Each party agrees it shall make no use of Confidential Information except for the purpose
of this Agreement. The receiving party will safeguard the disclosing party’s Confidential Information against unauthorized disclosure using the same degree of care as it uses for its own confidential information of like importance, but in any
event using no less than reasonable care. Any disclosure of the disclosing party’s Confidential Information to the receiving party’s employees or consultants will be under an appropriate individual confidentiality obligation with each such
employee and consultant. The receiving party is responsible for any disclosure of the disclosing party’s Confidential Information by the receiving party’s employees or consultants. 

 

	6.4	 Ownership. Except as otherwise expressly provided in this Agreement, all Confidential Information shall
remain the property of the disclosing party. 

  

	6.5	 Copies; Return or Destruction of Materials. Neither party will copy or duplicate any materials
containing Confidential Information except as necessary to comply with Applicable Law or to perform its obligations or exercise its rights under this Agreement. The parties will return or certify in writing the destruction of all materials
containing Confidential Information that have been provided by the other party, including all copies, upon demand by the disclosing party. The receiving party will treat any materials containing Confidential Information of the disclosing party that
are not destroyed or returned to the disclosing party in accordance with this Article 6. A party may elect to keep copies of Confidential Information for evidentiary purposes, to comply with Applicable Laws and to comply with such party’s
quality, regulatory and similar internal requirements, provided that such items shall continue to be treated as Confidential Information pursuant to this Agreement. Nothing in this Article 6 shall be construed to require the deletion of any items of
Confidential Information that are contained or stored in back up media, disaster recovery systems, or other electronic data storage systems, latent data or metadata, provided that such items shall continue to be treated as Confidential Information
pursuant to this Agreement. 

  
 Page 11 of 21 

	6.6	 Required Disclosure. In the event that, on the advice of legal counsel, the receiving party is compelled
to disclose the disclosing party’s Confidential Information, the receiving party will, to the extent reasonably possible, notify the disclosing party in advance of such disclosure about the need for any such disclosure so that the disclosing
party may seek a protective order or other remedy, if such remedy is reasonable under the circumstances. The receiving party will take reasonable action to ensure protection of the disclosed Confidential Information to the extent allowed by
Applicable Law. 

  

	6.7	 Publicity. Neither party may make any public announcement about or advertise the existence of this
Agreement or divulge its terms and conditions to third parties, other than attorneys, financial consultants or other advisors that are under a duty of confidentiality, without the prior written consent of the other party. 

 

	6.8	 Term of Obligations. Each party’s obligations under this Section 6 shall remain in effect
during the term of this Agreement plus five (5) years thereafter. 

  

	7.	 INTELLECTUAL PROPERTY RIGHTS 

 

	7.1	 License to Supplier. Buyer hereby grants to Supplier a
non-exclusive, nontransferable, non-sublicensable, revocable, fully paid up license to use Buyer Intellectual Property that is used or employed to perform Supplier’s obligations under the Agreement. Such
use shall be solely to design, develop and Manufacture the Products for supply to Buyer for the benefit of Buyer at the applicable Supplier Facility during the term of and pursuant to this Agreement, and for no other purpose. No other license to any
other Buyer Intellectual Property is granted, and none is to be implied. 

  

	7.2	 Intellectual Property Ownership. 

 

	 	7.2.1	 Buyer Intellectual Property. Buyer owns all Buyer Intellectual Property. 

 

	 	7.2.2	 Supplier Intellectual Property. Supplier owns all Supplier Intellectual Property. 

 

	 	7.2.3	 Developed Intellectual Property. As between the parties, Buyer owns all Developed Intellectual Property,
whether developed solely by Supplier or jointly by Supplier and Buyer or any third party. Supplier shall assign and hereby assigns all of its rights in and to such Developed Intellectual Property to Buyer. Supplier shall promptly disclose Developed
Intellectual Property to and shall execute and deliver documents appropriate to evidence ownership of the Developed Intellectual Property to Buyer. All Product documentation, drawings, prototypes and the like related to Developed Intellectual
Property are also the property of Buyer. 

  

	 	7.2.4	 Each party represents and warrants that neither it nor its personnel nor any other party retained by it to
assist in the performance of its obligations under this Agreement will decompile, reverse engineer, or disassemble any sample, device, prototype, hardware, software or other material, or portion thereof, made available to it by the other party
without the other party’s prior written consent. 

  

	7.3	 Failure to Supply License.  

 

	 	7.3.1	 Supplier License to Buyer. Supplier hereby grants to the Buyer a
non-exclusive, sub-licensable (through multiple tiers of sublicensees), assignable, worldwide, royalty-free, fully paid license to Supplier Intellectual Property and any
other Intellectual Property that is used, employed or necessary to make, have made, import, export, and to use, sell and otherwise exploit Products and replacements for Products. The scope of use of the above license grant is to make, have made,
import, export, and to use, sell and otherwise exploit Products and replacements for Products. 

  
 Page 12 of 21 

	 	7.3.2	 Limitation on Supplier License. Subject to the terms and conditions of this Agreement, Buyer shall not
exercise the Supplier license granted in Section 7.3.1, unless and until the occurrence of any one of the following events (“Trigger Condition”): 

 

	 	(i)	 Supplier fails for any reason to timely deliver units of the Product ordered by Buyer, including but not
limited to a failure to deliver Products which conform to the Specifications, which failure is not cured within thirty (30) days after written notice from Buyer; 

 

	 	(ii)	 Supplier wrongfully terminates this Agreement; 

 

	 	(iii)	 Supplier fails to comply with the requirements of Section 4.6; 

 

	 	(v)	 Supplier petitions for, consents to, or becomes subject to any relief under any bankruptcy, reorganization, or
moratorium statutes or similar debtor relief laws; or 

  

	 	(vi)	 Supplier fails to continue to do business in the ordinary course, either in general or with regard to the
Products. 

  

	 	7.3.3	 Supplier shall promptly (and in any event within thirty days) submit to Buyer the Supplier Intellectual
Property relating to the Products in the event Buyer undertakes to exercise its license rights following a Trigger Condition. 

  

	 	7.3.4	 Technical Support; Technology Transfer. In the event Buyer undertakes to exercise its license rights
following a Trigger Condition, Supplier shall provide technical support and training and otherwise assist Buyer or its designee in establishing manufacturing operations equivalent to the Manufacturing operations under this Agreement for the
production of each Product that utilizes Supplier Intellectual Property. Supplier shall provide Buyer with a full and enabling technology transfer (including any tooling, mask works, foundry access, or other critical items necessary for production)
relative to each Product. Except as expressly permitted under this Agreement, neither party may, directly or through others, distribute, copy, modify or create derivative works of the other party’s Intellectual Property. 

 

	 	7.3.5	 Access to Supplier Intellectual Property. Upon the occurrence of a Trigger Condition, Supplier shall
promptly provide Buyer or its designee with access to all Supplier Intellectual Property, Supplier Confidential Information and other items used, employed or necessary for the Manufacturing of the Product (including any specialized items, such as
tooling, molds, etc.) together with all information and training reasonably necessary for the Manufacture of the Products, as well as training for the use thereof. 

 

	 	7.3.6	 Bankruptcy. In the event that a bankruptcy petition is filed by or on behalf of Supplier and Supplier,
or a custodian or trustee acting on behalf of Supplier, rejects this Agreement, Buyer may elect to retain the license from Supplier pursuant to §365(n) of the federal bankruptcy code (11 U.S.C. § et seq.) or exercise any of its other
rights or elections under the bankruptcy code and shall be entitled to retain all of its license and use rights granted under the Agreement. 

  

	7.4	 Third Party Licenses. Supplier shall comply with and maintain in full force and effect all
license agreements with third parties pursuant to which Supplier is licensed to use the Intellectual Property of third parties that is used or employed by Supplier to perform its obligations under this Agreement. Supplier shall promptly notify Buyer
in writing of any allegation that Supplier is in breach of any such license agreement. Buyer may, but is not obligated to, cure any such alleged breach and recover the cost of such cure from Supplier, including without limitation, by set-off against amounts Buyer owes Supplier hereunder. 

  
 Page 13 of 21 

	7.5	 Intellectual Property Warranty and Indemnification. 

 

	 	7.5.1	 Non-Infringement. Supplier shall not provide Buyer any designs,
plans, models, samples, software, integrated circuits, reports, or other writings or products which it either knows or has reason to believe violate the valid patent, copyright, or other form of Intellectual Property right of a third party. Supplier
represents and warrants that the manufacture, use, sale and provision of the Product(s) by Supplier, and Buyer’s subsequent use and sale of the Product, will not infringe or violate the patent, copyright, or other property or proprietary
rights of any third party, except that the warranty in this subsection does not apply to any infringement or violation resulting from: (i) Specifications or other Buyer Intellectual Property provided by Buyer; or (ii) a combination of
other products with the Product at the request of Buyer or when Supplier did not supply, recommend, or procure such other products, or when Supplier objected to the combination of such other products with the Product. 

 

	 	7.5.2	 Rights in Intellectual Property. Each party represents and warrants to the other party that it owns all
right, title and interest in, or has all sufficient and valid right its use, its Intellectual Property (Buyer Intellectual Property or Supplier Intellectual Property as the case may be) as used or employed by it to design, develop, Manufacture and
distribute the Products, without restriction or encumbrance. 

  

	 	7.5.3	 Indemnity. Each party (in this context, the “indemnifying party”) shall defend, indemnify and
save harmless the other party and its officers, directors, employees, shareholders, agents or representatives (in this context, the “indemnified parties”) from all damages, costs and expenses (including attorney fees) related to a claim
that its Intellectual Property (Buyer Intellectual Property or Supplier Intellectual Property as the case may be) infringes a patent or other intellectual property right of any third party, provided, that the indemnified parties provide notice to
the indemnifying party of such claim no more than thirty (30) days after receipt of such claim. If the indemnified parties fails to notify the indemnifying party within thirty (30) days, the indemnifying party’s obligation to defend,
indemnify and save harmless the indemnified parties shall be reduced only to the extent the indemnifying party is prejudiced by the delay beyond thirty (30) days. If the use of any Products is enjoined as the result of a claim against Supplier
contemplated by this Section 7.5.3, at Buyer’s option, Supplier shall at its expense and as a first priority, work to either substitute a fully functionally equivalent product or process (as applicable) not subject to such injunction,
modify such Product or process (as applicable) so that it is no longer subject to such injunction, or obtain the right to continue using such Product or process (as applicable) so long as such Product or process meets all Buyer and regulatory
requirements. 

  

	7.6	 Patent Marking. Supplier shall place patent markings on, about or within Products or components in
accordance with written instructions provided by or on behalf of Buyer. 

  

	8.	 WARRANTIES AND REPRESENTATIONS  

 

	8.1	 Product Compliance. Supplier represents and warrants to Buyer that: (i) the Products delivered to
Buyer are not adulterated or misbranded within the meaning of the FD&C Act, (ii) all Products delivered to Buyer have been Manufactured in accordance with a quality system that is consistent with the applicable Quality Requirements and the
requirements set forth in any separate quality agreement between the parties; and (iii) the Manufacture, sale and delivery of Products does not violate any, and the Products conform to all, Applicable Laws. Supplier shall promptly notify
Buyer in writing if Supplier becomes aware that a Product or any applicable Quality Requirements may not comply with Applicable Law. 

  

	8.2	 Product Warranty. Supplier represents and warrants that each Product fully complies and will comply with
all applicable Specifications and applicable Quality Requirements and is and will be free from defects in materials and workmanship. If Supplier includes software in a Product,

  
 Page 14 of 21 

	 	
Supplier warrants that any computer software provided with or incorporated into a Product (i) is and will be free of viruses, worms, and other components designed to erase, disable, or
otherwise cause harm to computer systems, and (ii) does not contain Publicly Available Software except as provided herein. If Publicly Available Software is included in a Product by Supplier, Supplier represents and warrants that it has
complied with all licensing requirements associated with the use of such software in the Products and agrees to provide information about such compliance in response to a written request from Buyer. Supplier shall inform Buyer in writing no more
than two (2) days after Supplier learns of any actual or potential problems relating to the performance of any Product or any similar product manufactured by Supplier for a third party.  

 

	8.3	 Government Watch List. Supplier represents and warrants that neither Supplier, nor any parent,
subsidiary, affiliate of Supplier, nor any Personnel, nor any sub-supplier of Supplier, is included in or listed on: (i) the List of Excluded Individuals/Entities maintained by the HHS Office of Inspector
General pursuant to 42 U.S.C. Sections 1320a-7, 13955ccc, 1320c-5 and regulations promulgated thereunder, which, as of the Effective Date, can be searched at the
internet website of http://exclusions.oig.hhs.gov/ (“OIG List”); (ii) the Excluded Parties List System maintained by the United States General Services Administration which, as of the Effective Date, can be searched at the internet
website of http://epls.arnet.gov (the “GSA List”); or (iii) any Restricted Party List. Supplier shall immediately notify Buyer if Supplier, any parent, subsidiary or affiliate of Supplier or Personnel, or any sub-supplier of Supplier, should come to be included on the OIG List, the GSA List or any Restricted Party List.  

 

	8.4	 Compliance with Agreement. Supplier represents and warrants that all of its employees, agents,
contractors and consultants whose services may be used to fulfill the obligations under this Agreement are or will be informed of the terms of this Agreement to the extent necessary to comply with its terms and that all such persons are sufficiently
obligated to Supplier, by contract or otherwise, to fully comply with all provisions of this Agreement. 

  

	8.5	 Conflicts. Supplier represents and warrants to Buyer that the execution of this Agreement and
Supplier’s performance hereunder is within its duly authorized powers and does not conflict with any other contract or obligation of Supplier. Supplier shall not enter into any agreement or understanding whether written or oral, during the term
of this Agreement which conflicts or is inconsistent with the terms of this Agreement. 

  

	9.	 INDEMNIFICATION 

 

	9.1	 Indemnifications. 

 

	 	9.1.1	 In addition to other indemnification obligations provided in this Agreement, Supplier shall indemnify, defend
and hold harmless Buyer and its officers, directors, employees, shareholders, agents and representatives from and against and in respect of any and all alleged or actual demands, claims, actions or causes of action, alleged or actual claims of
negligence, assessments, losses, damages, liabilities, interest and penalties, costs and expenses (including, without limitation, reasonable legal fees and disbursements incurred in connection therewith) (collectively, “Claims”)
resulting from, arising out of, or imposed upon or incurred by any person to be indemnified hereunder by reason of Supplier’s alleged negligence or breach of the Agreement. Buyer will notify Supplier promptly after Buyer becomes aware of any
claim by any third party with respect to which Buyer would be entitled to indemnification hereunder. Supplier shall, at no cost to Buyer, cooperate as requested by Buyer in the defense of any Claim for which indemnity may be sought.

  

	 	9.1.2	 In addition to other indemnification obligations provided in this Agreement, Buyer shall indemnify, defend and
hold harmless Supplier and its officers, directors, employees, shareholders, agents and representatives from and against and in respect of any and all third-

  
 Page 15 of 21 

	 	
party Claims resulting from, arising out of, or imposed upon or incurred by any person to be indemnified hereunder by reason of Buyer’s alleged negligence or breach of the Agreement.
Supplier will notify Buyer promptly after Supplier becomes aware of any claim by any third party with respect to which Supplier would be entitled to indemnification hereunder. Buyer shall, at no cost to Supplier, cooperate as requested by Supplier
in the defense of any Claim for which indemnity may be sought. 

  

	9.2	 Limitation of Remedies. Except for their obligations under Section 6 (Confidentiality and
Publicity), and any other section that specifically refers to this Limitation of Remedies Section, IN NO EVENT WILL A PARTY BE LIABLE TO THE OTHER FOR ANY CONSEQUENTIAL, INDIRECT, INCIDENTAL, EXEMPLARY OR SPECIAL DAMAGES OF ANY KIND; provided,
however, that this Section 9.2 shall not be construed to limit either party’s indemnification rights or obligations under this Section 9. 

  

	9.3.	 Insurance. Supplier shall, at its sole cost and expense, obtain and at all times during the term of this
Agreement maintain insurance with the following minimum coverage and limits: (a) workers’ compensation insurance in accordance with all applicable legal requirements; (b) commercial general liability insurance on an occurrence basis
with minimum combined single limit coverage of $1,000,000 per occurrence and $3,000,000 general aggregate for bodily injury and property damage liability; and (c) product liability of $2,000,000 per occurrence covering all
Products. Supplier will name “Sight Sciences, Inc., its subsidiaries and affiliates” as “Additional Insured”, with primary, non-contributory coverage, under Supplier’s insurance
policies. Supplier shall furnish Buyer written evidence of such insurance and shall provide at least thirty (30) days’ prior written notice of change in coverage levels or termination of such insurance. 

 

	10.	 TERM AND TERMINATION 

 

	10.1	 Term. This Agreement will become effective on the Effective Date for an initial term of three
(3) years (the “Initial Term”). Unless earlier terminated, this Agreement will thereafter automatically renew for additional one-year periods, unless either party provides the other with notice
of non-renewal at least ninety (90) days before the end of the then-current term. 

  

	10.2	 Termination. Buyer may terminate this Agreement for any reason upon written notice to Supplier of no
less than one hundred eighty (180) days. Buyer may terminate this Agreement or any Purchase Order for cause upon a material default by Supplier, which default either remains uncured for thirty (30) days after written notice thereof is
given to Supplier. If either party becomes or is declared insolvent or bankrupt, admits in writing of its inability to pay its debts generally as they become due, is the subject of any proceedings relating to its liquidation or insolvency or for the
appointment of a receiver for it, makes an assignment for the benefit of all or substantially all of its creditors, or enters into an agreement for the composition, extension, or readjustment of all or substantially all of its obligations, then the
other party may, by giving written notice thereof to such party, terminate this Agreement as of a date specified in such notice of termination 

  

	10.3	 Effect of Expiration or Termination:  

 

	 	10.3.1	 Orders. Unless otherwise provided in a purchase order, upon termination or expiration of this Agreement,
all then-outstanding orders for Products shall survive. 

  

	 	10.3.2	 License. In the event of a non-renewal or termination by
Supplier of this Agreement with less notice than required by Section 4.6 (Discontinuation), Buyer will have the rights accorded to it under Section 7.3 (Failure to Supply License) as though Supplier had elected to exit the business.

  
 Page 16 of 21 

	 	10.3.3	 Last Time Buy. In event of termination or expiration of this Agreement, Buyer shall have a right to
place an order for a last time buy pursuant to Section 4.6 (Discontinuation) during the remainder of the term of this Agreement and for ninety (90) days thereafter as though Supplier had elected to exit the business. Supplier shall be
required to supply Products sufficient to satisfy Buyer’s then current demand planning forecast for a period of at least twelve (12) months. 

  

	 	10.3.4	 Return to Buyer. At the earlier of Buyer’s written request or Product delivery to fulfill the last
order placed under this Agreement, Supplier shall promptly return all applicable Buyer Confidential Information and Buyer property, return or securely destroy the records in Supplier’s possession as directed by Buyer and execute such
documents and take other action as reasonably requested by Buyer in connection therewith. 

  

	10.4	 Survival. All provisions which are continuing in nature, including but not limited to Sections 2.5.4
(Acceptance and Rejection); 4 (Production and Quality), 5 (Legal and Regulatory Compliance), 6 (Confidentiality and Publicity), 7 (Intellectual Property Rights), 8 (Warranties and Representations), 9 (Indemnification), 10 (Term and Termination) and
11 (Miscellaneous), will survive termination of this Agreement. 

  

	11.	 MISCELLANEOUS 

 

	11.1	 Force Majeure. A party’s obligations under this Agreement, including any delays in Product
deliveries, will be excused by a Force Majeure event only to the degree affected, provided that the party affected by the Force Majeure event makes reasonable efforts to avoid being so affected and promptly delivers written notice to the other party
upon learning of the Force Majeure event, which notice must include a detailed description of the event and its anticipated effect on the party’s ability to perform its obligations. Upon giving notice to the other party, the affected party is
excused from the performance of its obligations under this Agreement only to the extent and only for the period that its performance of such obligations is prevented by the Force Majeure event, except that this clause does not apply to
Supplier’s obligation to perform its disaster recovery plan. During the period that the performance by a party has been suspended by reason of a Force Majeure event, the other party may suspend the performance of all or part of its obligations
to the extent that such suspension is commercially reasonable. 

  

	11.2	 Assignment. This Agreement and/or any portion thereof is assignable by Buyer, provided that the assignee
assumes the rights and obligations of Buyer corresponding to the entire Agreement or the assigned portions thereof. This Agreement or any portion of it may not be assigned by Supplier without the prior written consent of Buyer.

  

	11.3	 Notices. Notices given under the Agreement must be in writing and must be either delivered in person
(including express courier, such as Federal Express) or sent by United States certified or registered mail, postage and certification prepaid, to the other party, at the address at the beginning of this Agreement. Notices are effective upon
delivery. A party may change its address for notice by giving the other party notice in accordance with this section. 

  

	11.4	 Consents. Any approval, authorization or consent required by this Agreement must be in writing, duly
signed by an authorized representative of the granting party. The withholding of an approval, authorization or consent for regulatory, quality, or competitive reasons shall not be deemed unreasonable. 

 

	11.5	 Relationship of the Parties. Nothing contained in the Agreement creates a joint venture, partnership,
agency or similar endeavor between the parties. Each party is acting solely as an independent contractor, and neither party has any power or authority to direct or indirectly bind or act on behalf of the other. It is understood that, except as
expressly provided in this Agreement, nothing prevents Buyer from developing products similar to the Products or from sourcing products similar to the Products from another vendor. 

  
 Page 17 of 21 

	11.6	 Governing Law. This Agreement will be construed in accordance with and governed by the laws of the State
of California, USA, without giving effect to any choice of law rule that would cause the application of the laws of any other jurisdiction. 

  

	11.7	 Dispute Escalation; Arbitration. The parties will in good faith endeavor to resolve any disputes or
differences of interpretation of this Agreement amicably, through dialog and cooperation. In the event a dispute or difference is not promptly resolved at operational levels of the two organizations, the parties shall escalate it for a good faith
effort to achieve an amicable resolution at a senior business management level. All disputes arising out of or in connection with this Agreement (including the existence, validity or termination of this Agreement) that are not amicably resolved
within a reasonable time period in accordance with this Section 11.7 shall be submitted to the International Court of Arbitration of the International Chamber of Commerce and shall be finally settled under the Rules of Arbitration of the
International Chamber of Commerce by three (3) arbitrators appointed in accordance with the said Rules. Arbitration will take place in San Francisco, California, and proceedings will be conducted in English. Such arbitrators shall apply
California law. The decision or award of the arbitrators shall be in writing and is final and binding on both parties. 

  

	11.8	 Entire Agreement and Modifications. This Agreement sets forth the entire agreement between the parties
and supersedes all prior agreements, understandings and discussions regarding the subject matter hereof. No amendment, change, modification of any provision of this Agreement will be binding unless set forth in a written document signed by the
parties. 

  

	11.9	 Waiver. No waiver by either party of any default of the other party will be held to be a waiver of any
other or subsequent default. No waiver shall be effective unless it is in writing and is signed by the party against which it is asserted. 

  

	11.10	 Severability. If a provision contained or referred to in this Agreement is determined to be legally
invalid or unenforceable, that provision will be ineffective to the extent of the invalidity or unenforceability without affecting the remaining provisions of this Agreement, which will continue to be valid and enforceable to the fullest extent
permitted by law. 

  
 Page 18 of 21 

 The parties have caused this Agreement to be executed as of the Effective Date. 

 

									
	SIGHT SCIENCES, INC.	 		 	 PETER’S TECHNOLOGY (SUZHOU) CO.,
LTD.

									
					
	By	 	 /s/ Sam Park
	 		 	By	 	 /s/ Calvin Kuo

				
		 	Sam Park, Chief Operating Officer	 		 	 Calivn Kuo

		 		 		 	(print name)
					
		 		 		 	Title	 	 General Manager

					
	Date	 	 Jan 14th 2021
	 		 	Date	 	 Jan 15th, 2021

  
 Page 19 of 21 

 EXHIBIT A 

PRODUCTS; PRODUCT PRICING 

[Intentionally Omitted] 

  
 Page 20 of 21 

 EXHIBIT B 

SPECIFICATIONS 

[Intentionally Omitted] 

  
 Page 21 of 21Exhibit 10.1

 

EXECUTIVE EMPLOYMENT
AGREEMENT

 

This EXECUTIVE EMPLOYMENT
AGREEMENT (this “Agreement”) is made and entered into as of this June 22, 2021 and effective as of July 1, 2021 (“Effective
Date”), by and between Ault Global Holdings, Inc., a Delaware corporation with an address of 11411 Southern Highlands Parkway,
Suite 240, Las Vegas, NV 89141 (the “Company”) and Christopher K. Wu, an individual (the “Executive”).

 

W I T N E S S E T H:

 

WHEREAS,
the Executive desires to be employed by the Company as its Executive Vice President of Alternative Investments of the Company and as the
President of Ault Alliance, Inc., the Company’s wholly owned subsidiary, and the Company wishes to employ Executive in each such
capacity;

 

NOW, THEREFORE,
in consideration of the foregoing recitals and the respective covenants and agreements of the parties contained in this Agreement, the
Company and Executive hereby agree as follows:

 

1.           Employment
and Duties. The Company agrees to employ and Executive agrees to serve as the Company's Executive Vice President of Alternative Investments.
The rights, duties and responsibilities of Executive shall include providing executive leadership of business development, marketing and
communications functions to promote sustainable growth of the Company, working closely with the Chief Executive Officer, using his business
units to build a cohesive organization that operates with an efficient, consistent approach to addressable markets and the investor community,
and such other responsibilities as are set forth as Annex A hereto. Executive shall report to the Board of Directors (the
“Board”) of the Company, the Executive Chairman of the Board and the Chief Executive Officer.

 

Executive shall devote a sufficient
amount of his working time and efforts during the Company's normal business hours to the business and affairs of the Company and its subsidiaries
in order to diligently and faithfully perform his duties and responsibilities duly assigned to him pursuant to this Agreement. Executive
shall be permitted to carry on additional activities provided that none of the additional activities interferes with the performance of
the duties and responsibilities of Executive or are determined to be inconsistent with the position, standing, stature, reputation or
best interests of the Company; nothing in this Section 1, shall prohibit Executive from (a) serving as a director or member of
a committee of entities that do not, in the reasonable good faith determination of the Board, compete with the Company or otherwise create,
or could create, in the reasonable good faith determination of the Board, a conflict of interest with the business of the Company; (b)
delivering lectures, fulfilling speaking engagements, and any writing or publication relating to his area of expertise; (c) serving as
a director or trustee of any governmental, charitable or educational organization; or (d) engaging in additional activities in connection
with personal and/or business investments and community affairs.

 

2.           Term.
The term of this Agreement shall commence on the Effective Date and shall continue through December 31, 2023, subject to renewal with
each party’s consent for another twelve (12) months (the “Term”) unless earlier terminated by either party providing
the other party with written notice of his or its intention to terminate this Agreement upon thirty (30) days’ notice.

 

3.          Place
of Employment. Executive's services may, but need not, be performed at the Company's offices at the address in the first paragraph
above. The Executive may from time to time perform his duties to the Company at another location or locations, at the discretion of Executive.
 The parties acknowledge, however, that Executive may be required to travel in connection with the performance of his duties hereunder.

 

4.           Base
Salary. For all services to be rendered by Executive pursuant to this Agreement, the Company agrees to pay Executive during the Term
a base salary at an annual rate of $300,000 (the “Base Salary”). In addition, the Base Salary as then in effect shall
be subject to such further upward adjustments as shall be determined by the Board in its sole discretion. The Base Salary shall be paid
in periodic installments in accordance with the Company's regular payroll practices.

 

5.           Bonuses.
 Executive will be entitled to Bonuses as follows:

 

a.       A
signing bonus in the amount of $25,000, payable upon the Effective Date;

 

    	 		 

    	 

    

 

b.       During
the Term, the Executive shall be entitled to an annual bonus (the “Annual Bonus”) if the Company meets or exceeds criteria
adopted by the Compensation Committee of the Board for earning Bonuses which shall be adopted by the Compensation Committee annually.
Bonuses shall be paid by the Company to the Executive promptly after determination that the relevant targets have been met, it being understood
that the attainment of any financial targets associated with any bonus shall not be determined until following the completion of the Company’s
annual audit and public announcement of such results and shall be paid promptly following the Company’s announcement of earnings.
The Annual Bonus may consist of cash, the Company’s Class A Common Stock (the “Common Stock”), or a combination
of the two. Notwithstanding the foregoing, in the event that the Executive’s employment is terminated as of a date other than January
1 of any year, then the calculation of the bonus shall be prorated accordingly.

 

c.       During
the initial eighteen (18) months of the Term, the Executive shall be entitled to receive a cash incentive payment equal to 1.25% of third-party
debt that the Executive is directly involved in obtaining for the Company and/or investments in which the Company participates. After
eighteen (18) months, the cash incentive payment shall be reduced to 0.75%. If the Company makes an investment as a direct result of the
Executive’s efforts, then the Executive shall be entitled to receive a cash incentive payment equal to 6% of the realized gains,
if any, from the investment(s). The 6% cash incentive payment shall be based upon the amount of net realized gains in a calendar year
and shall reset annually on January 1st. If the Company receives management fees in connection with an investment as a direct
result of the Executive’s efforts or, in the Company’s discretion, the Executive contributes significantly to the transaction
and subsequent management, the Executive may be eligible to receive a portion of the management fee commensurate with the Executive’s
contribution. The payment of any management fee shall be determined on a case-by-case basis.

 

d.       The
Company shall grant to Executive an option to purchase 400,000 shares of Common Stock exercisable for a period of seven (7) years at a
per share exercise price of equal to the closing price of the Common Stock on the Effective Date. The options shall vest ratably over
48 months beginning with the first month after the grant date. Vesting shall be contingent upon receiving shareholder approval of the
Company’s 2021 Stock Incentive Plan.

 

e.       The
Company shall grant to Executive 100,000 shares of Common Stock (the “Stock Award”), which shall be issued under the
Company’s 2021 Stock Incentive Plan. The Stock Award shall vest in 12.5% increments, semi-annually, on May 15th and November
15th over a period of 48 months, beginning with the first month after the Effective Date. Vesting shall be contingent upon
receiving NYSE American approval of the Company’s 2021 Stock Incentive Plan.

 

f.       All
bonus or other incentive-based or equity-based compensation provided to the Executive shall be subject to the Company’s Clawback
Policy for Restatements, which is appended hereto as Annex B.

 

6.           Expenses.
Executive shall be entitled to prompt reimbursement by the Company for all reasonable and necessary travel, entertainment, and other expenses
incurred by Executive while employed (in accordance with the policies and procedures established by the Company for its executive officers)
in the performance of his duties and responsibilities under this Agreement; provided, that Executive shall properly account for such expenses
in accordance with Company policies and procedures. Notwithstanding anything herein or in the Company’s policies and procedures
to the contrary, Executive shall be reimbursed for the cost of his cellular phone, internet services and a laptop used for the Company’s
business.

 

7.           Benefits.

 

(a)           Benefit
Plans. During the term of this Agreement, on the later of (i) the first day of the month after the Effective Date or (ii) the date
upon which the respective Benefit Plans (as defined below) are available for the Company’s employees, the Executive shall be eligible
to participate in incentive, stock purchase, savings, retirement, and welfare benefit plans, including, without limitation, health, medical,
dental, vision, life (including accidental death and dismemberment) and disability insurance plans (collectively, “Benefit Plans”),
in the same manner and at the same levels as the Company makes such opportunities available to the Company's managerial or salaried executive
employees. In the event that any waiting periods or other eligibility requirements are imposed prior to Executive becoming eligible for
any of such Benefit Plans, then the Company shall reimburse Executive for the cost(s) incurred by Executive in maintaining his current
benefit plans during any such waiting or eligibility periods.

 

    	 	2	 

    	 

    

 

(b)       Vacation.
The Executive shall be entitled to four (4) weeks of vacation (in addition to the usual national holidays) during each contract year during
which he serves hereunder. Such vacation shall be taken at such time or times as will be mutually agreed between the Executive and the
Company. Vacation not taken during a calendar year may be carried forward, with a maximum accrual of eight (8) weeks.

 

(c)       Severance
Compensation. Upon termination of Executive's employment (other than upon the expiration of the Term): (i) Executive shall be entitled
to receive any earned but unpaid Base Salary through the termination date; (ii) Executive shall be entitled to receive any and all reasonable
expenses paid or incurred by the Executive in connection with and related to the performance of his duties and responsibilities for the
Company during the period ending on the termination date, and (iii) Executive shall be entitled to receive any accrued but unused vacation
time through the termination date. Further, unless the Executive's employment is terminated as a result of his death or Disability or
for Cause or Executive terminates his employment without Good Reason, then upon the termination or non-renewal of Executive's employment,
the Company shall pay to Executive a severance payment as follows: the Company shall pay Executive an amount equal to six (6) months of
Executive's Base Salary (as in effect immediately prior to the termination date), and (b); and a prorated Bonus amount equal to the Annual
Bonus generated during the fraction of the year that the Executive has been employed as of the termination date, payable in accordance
with standard bonus payment practices of the Company.

 

For purposes of this Agreement,
the following terms shall have the meanings set forth below:

 

“Cause”
shall mean the willful and continued failure of the Executive to perform substantially his duties and responsibilities for the Company
(other than any such failure resulting from Executive’s death or Disability) after a written demand by the Board for substantial
performance is delivered to the Executive by the Company, which specifically identifies the manner in which the Board believes that the
Executive has not substantially performed his duties and responsibilities, which willful and continued failure is not cured by the Executive
within thirty (30) days of his receipt of such written demand; (b) the conviction of, or plea of guilty or nolo contendere to,
a felony, or (c) fraud, dishonesty or gross misconduct which is materially and demonstratively injurious to the Company.

 

“Disability”
shall mean a physical or mental disability that prevents the performance by the Executive, with or without reasonable accommodation, of
his duties and responsibilities hereunder for a period of not less than an aggregate of three (3) months during any six (6) consecutive
months.

 

“Good Reason”
shall mean (1) the assignment, without the Executive’s consent, to the Executive of duties that are significantly different from,
and that result in a diminution of, the duties that he assumed on the Effective Date or the imposition of a requirement that Executive
report to any person other than the Board and/or the Chief Executive Officer; (2) the assignment, without the Executive’s consent,
to the Executive of a title that is different from and subordinate to the titles Executive Vice President of Alternative Investments of
the Company or President of Ault Alliance, Inc., provided, however, for the absence of doubt following a Change of Control, should the
Executive cease to retain either the title or responsibilities assumed on the Effective Date, or Executive is required to serve in a diminished
capacity or lesser title in a division or unit of another entity (including the acquiring entity), such event shall constitute Good Reason
regardless of the title of Executive in such acquiring company, division or unit; (3) material breach by the Company of this Agreement;
and (4) the relocation of Executive’s regular office to a location that is more than twenty-five (25) miles from Executive’s
current office.

 

8.       Confidential
Information.

 

(a)       Disclosure
of Confidential Information. The Executive recognizes, acknowledges and agrees that he has had and will continue to have access to
secret and confidential information regarding the Company, its subsidiaries and their respective businesses (“Confidential Information”),
including but not limited to, its products, methods, formulas, software code, patents, sources of supply, customer dealings, data, know-how,
trade secrets and business plans, provided Confidential Information shall not include information and know how that was known to Executive
prior to his employment hereunder, is in or does hereafter become part of the public domain, or becomes known to others through no fault
of the Executive. The Executive acknowledges that such Confidential Information is of great value to the Company, is the sole property
of the Company, and has been and will be acquired by him in confidence. In consideration of the obligations undertaken by the Company
herein, the Executive will not, at any time, during or after his employment hereunder, reveal, divulge or make known to any person, any
Confidential information acquired by the Executive during the course of his employment, which is treated as confidential by the Company,
and not otherwise in the public domain. The provisions of this Section 8 shall survive the termination of the Executive’s employment
hereunder for three years.

 

    	 	3	 

    	 

    

 

(b)       The
Company acknowledges that notwithstanding the foregoing, Executive, through his extensive experience and contacts in the industry is already
in possession of significant information and know how regarding the Company, its products and the industry within which it operates. Nothing
herein shall be deemed to restrict Executive, during the term hereof or thereafter, from disclosing or using any such information.

 

(c)       In
the event that the Executive’s employment with the Company terminates for any reason, the Executive shall deliver forthwith to the
Company any and all originals and copies or inform the Company in writing that the Executive has destroyed all originals and copes, including
those in electronic or digital formats, of Confidential Information; provided, however, that Executive shall be entitled to retain (i)
papers and other materials of a personal nature, including, but not limited to, photographs, correspondence, personal diaries, calendars
and rolodexes, personal files and phone books, (ii) information showing his compensation or relating to reimbursement of expenses, (iii)
information that he reasonably believes may be needed for tax purposes and (iv) copies of plans, programs and agreements relating to his
employment, or termination thereof, with the Company.

 

9.       Non-Competition
and Non-Solicitation. To the fullest extent permissible under applicable law, during the term of this Agreement and for a period of
two (2) years following termination of this Agreement (the “Separation Period”):

 

(a)       The
Executive agrees and acknowledges that the Confidential Information that the Executive has already received and will receive is valuable
to the Company and that its protection and maintenance constitutes a legitimate business interest of the Company, to be protected by the
non-competition restrictions set forth herein. The Executive agrees and acknowledges that the non-competition restrictions set forth herein
are reasonable and necessary and do not impose undue hardship or burdens on the Executive. The Executive also acknowledges that the products
and services developed or provided by the Company, its affiliates and/or its clients or customers are or are intended to be sold, provided,
licensed and/or distributed to customers and clients primarily in and throughout the United States (the “Territory”)
(to the extent the Company comes to operate, either directly or through the engagement of a distributor or joint or co-venturer, or sell
a significant amount of its products and services to customers located, in areas other than the United States during the term of the Term,
the definition of Territory shall be automatically expanded to cover such other areas), and that the Territory, scope of prohibited competition,
and time duration set forth in the non-competition restrictions set forth below are reasonable and necessary to maintain the value of
the Confidential Information of, and to protect the goodwill and other legitimate business interests of, the Company, its affiliates and/or
its clients or customers. The provisions of this Section 9 shall survive the termination of the Executive’s employment hereunder.

 

(b)       The
Executive hereby agrees and covenants that he shall not, during the Term and any Separation Period, without the prior written consent
of the Company, directly or indirectly, in any capacity whatsoever, including, without limitation, as an employee, employer, consultant,
principal, partner, shareholder, officer, director or any other individual or representative capacity (other than (i) as a holder of less
than ten percent (10%) of the outstanding securities of a company whose shares are traded on any national securities exchange or (ii)
as a limited partner, passive minority interest holder in a venture capital fund, private equity fund or similar investment entity which
holds or may hold an equity or equity-linked security position in portfolio companies that are directly competitive with the Company’s
products or services; provided however, that the Executive shall be precluded from serving as an operating partner, general partner, manager
or governing board designee with respect to such portfolio companies), or whether on the Executive's own behalf or on behalf of any other
person or entity or otherwise howsoever, during the Term and the Separation Period and thereafter to the extent described below, within
the Territory:

 

(1)       Finance,
lend, acquire or invest on behalf of another investment company, lender or financing vehicle that the Executive joins in any capacity,
a financing or investment opportunity that the Executive and the Company has had substantive financing or investment discussions with
in the preceding one (1) year from the Executive’s termination date without prior written consent from the Company.

 

(2)       Recruit,
solicit or hire, or attempt to recruit, solicit or hire, any employee, or independent contractor of the Company to leave the employment
(or independent contractor relationship) thereof, whether or not any such employee or independent contractor is party to an employment
agreement, for the purpose of directly competing with the business of the Company;

 

    	 	4	 

    	 

    

 

(3)       Attempt
in any manner to solicit or accept from any customer of the Company, with whom Executive had significant contact during Executive’s
employment by the Company (whether under this Agreement or otherwise), business of the kind or competitive with the business done by the
Company with such customer or to persuade or attempt to persuade any such customer to cease to do business or to reduce the amount of
business which such customer has customarily done or might do with the Company, or if any such customer elects to move its business to
a person other than the Company, provide any services of the kind or competitive with the business of the Company for such customer, or
have any discussions regarding any such service with such customer, on behalf of such other person; or

 

(4)       Interfere
with any relationship, contractual or otherwise, between the Company and any other party, including, without limitation, any supplier,
distributor, co-venturer or joint venturer of the Company, for the purpose of soliciting such other party to discontinue or reduce its
business with the Company.

 

For purposes hereof, a business
shall not be deemed to be in competition with the business of the Company, nor shall any products or services be deemed to compete with
those of the Company, unless the Company presently produces, sells or distributes or, has, during the Term, plans to produce, sell or
distribute, such products or services.

 

With respect to the activities
described in Paragraphs (1), (2), (3) and (4) above, the restrictions of this Section 9(b) shall continue during the Term and until termination
of the Separation Period following the termination of this Agreement or of the Executive’s employment with the Company (including
upon expiration of this Agreement), whichever occurs later; provided, however that, in the event this Agreement or Executive’s employment
is terminated by Executive for Good Reason or is terminated by Company without Cause, then the restrictions contained in Section 9(b)
shall continue during the Term, and not beyond.

 

10.       Section
409A. The provisions of this Agreement are intended to comply with Section 409A of the Code and any final regulations and guidance
promulgated thereunder (“Section 409A”) and shall be construed in a manner consistent with the requirements for avoiding
taxes or penalties under Section 409A. The Company and Executive agree to work together in good faith to consider amendments to this Agreement
and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income
recognition prior to actual payment to Executive under Section 409A.

 

To the extent that Executive will be
reimbursed for costs and expenses or in-kind benefits, except as otherwise permitted by Section 409A, (a) the right to reimbursement or
in-kind benefits is not subject to liquidation or exchange for another benefit, (b) the amount of expenses eligible for reimbursement,
or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to
be provided, in any other taxable year; provided that the foregoing clause (b) shall not be violated with regard to expenses reimbursed
under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period
the arrangement is in effect and (c) such payments shall be made on or before the last day of the taxable year following the taxable year
in which you incurred the expense.

 

A termination of employment shall not
be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or
following a termination of employment unless such termination constitutes a “Separation from Service” within the meaning of
Section 409A and, for purposes of any such provision of this Agreement references to a “termination,” “termination of
employment” or like terms shall mean Separation from Service.

 

Each installment payable hereunder shall
constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b), including Treasury Regulation Section 1.409A-2(b)(2)(iii).
Each payment that is made within the terms of the “short-term deferral” rule set forth in Treasury Regulation Section 1.409A-1(b)(4)
is intended to meet the “short-term deferral” rule. Each other payment is intended to be a payment upon an involuntary termination
from service and payable pursuant to Treasury Regulation Section 1.409A-1(b)(9)(iii), et. seq., to the maximum extent permitted by that
regulation, with any amount that is not exempt from Code Section 409A being subject to Code Section 409A.

 

    	 	5	 

    	 

    

 

Notwithstanding anything to the contrary
in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s
termination, then only that portion of the severance and benefits payable to Executive pursuant to this Agreement, if any, and any other
severance payments or separation benefits which may be considered deferred compensation under Section 409A (together, the “Deferred
Compensation Separation Benefits”), which (when considered together) do not exceed the Section 409A Limit (as defined herein)
may be made within the first six (6) months following Executive’s termination of employment in accordance with the payment schedule
applicable to each payment or benefit. Any portion of the Deferred Compensation Separation Benefits in excess of the Section 409A Limit
otherwise due to Executive on or within the six (6) month period following Executive’s termination will accrue during such six (6)
month period and will become payable in one lump sum cash payment on the date six (6) months and one (1) day following the date of Executive’s
termination of employment. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment
schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following termination
but prior to the six (6) month anniversary of Executive’s termination date, then any payments delayed in accordance with this paragraph
will be payable in a lump sum as soon as administratively practicable after the date of Executive’s death and all other Deferred
Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit.

For purposes of this Agreement, “Section
409A Limit” will mean a sum equal (x) to the amounts payable prior to March 15 following the year in which Executive terminations
plus (y) the lesser of two (2) times: (i) Executive’s annualized compensation based upon the annual rate of pay paid to Executive
during the Company’s taxable year preceding the Company’s taxable year of Executive’s termination of employment as determined
under Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any IRS guidance issued with respect thereto; or (ii) the maximum amount that
may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s employment
is terminated.

 

11.       Golden
Parachute Limitation. Notwithstanding any other provision of this Agreement, in the event that it shall be determined that the aggregate
payments or distributions by the Company to or for the benefit of Executive, whether paid or payable or distributed or distributable pursuant
to the terms of this Agreement or otherwise (the “Payments”), constitute “excess parachute payments” (as
such term is defined under Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”) or any successor
provision, and the regulations promulgated thereunder (collectively, “Section 280G”)) that would be subject to the
excise tax imposed by Section 4999 of the Code or any successor provision (collectively, “Section 4999”) or any interest
or penalties with respect to such excise tax (the total excise tax, together with any interest and penalties, are hereinafter collectively
referred to as the “Excise Tax”), then the Payments shall be either (a) delivered in full, or (b) delivered to such
lesser extent that would result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking
into account the applicable Federal, state or local income and employment taxes and the Excise Tax, results in the receipt by Executive,
on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be subject to
the Excise Tax. In the event that the Payments are to be reduced pursuant to this Section 11, such Payments shall be reduced such that
the reduction of compensation to be provided to Executive as a result of this Section 11 is minimized. In applying this principle, the
reduction shall be made in a manner consistent with the requirements of Section 409A and where two economically equivalent amounts are
subject to reduction but payable at different times, such amounts shall be reduced on a pro rata basis (but not below zero). All calculations
required pursuant to this Section 11 shall be performed in good faith by nationally recognized registered public accountants or tax counsel
selected by the Company.

 

12.       Miscellaneous.

 

(a)         The
Executive acknowledges that the services to be rendered by him under the provisions of this Agreement are of a special, unique and extraordinary
character and that it would be difficult or impossible to replace such services. Furthermore, the parties acknowledge that monetary damages
alone would not be an adequate remedy for any breach by the Executive of Section 8 or Section 9 of this Agreement. Accordingly, the Executive
agrees that any breach or threatened breach by him of Section 8 or Section 9 of this Agreement shall entitle the Company, in addition
to all other legal remedies available to it, to apply to any court of competent jurisdiction to seek to enjoin such breach or threatened
breach. The parties understand and intend that each restriction agreed to by the Executive hereinabove shall be construed as separable
and divisible from every other restriction, that the unenforceability of any restriction shall not limit the enforceability, in whole
or in part, of any other restriction, and that one or more or all of such restrictions may be enforced in whole or in part as the circumstances
warrant. In the event that any restriction in this Agreement is more restrictive than permitted by law in the jurisdiction in which the
Company seeks enforcement thereof, such restriction shall be limited to the extent permitted by law. The remedy of injunctive relief herein
set forth shall be in addition to, and not in lieu of, any other rights or remedies that the Company may have at law or in equity.

 

(b)         Neither
the Executive nor the Company may assign or delegate any of their rights or duties under this Agreement without the express written consent
of the other; provided, however, that the Company shall have the right to delegate its obligation of payment of all sums
due to the Executive hereunder, provided that such delegation shall not relieve the Company of any of its obligations hereunder.

 

    	 	6	 

    	 

    

 

(c)         During
the term of this Agreement, the Company (i) shall indemnify and hold harmless Executive and his heirs and representatives as provided
under the Company’s certificate of incorporation, bylaws and indemnification agreement and (ii) shall cover Executive under the
Company’s directors’ and officers’ liability insurance on the same basis as it covers other senior executive officers
and directors of the Company.

 

(d)       This
Agreement constitutes and embodies the full and complete understanding and agreement of the parties with respect to the Executive’s
employment by the Company, supersedes all prior understandings and agreements, whether oral or written, between the Executive and the
Company, and shall not be amended, modified or changed except by an instrument in writing executed by the party to be charged (it being
understood that, pursuant to Section 7, the Benefit Plans and relevant option agreements shall govern with respect to the subject matter
thereof). The invalidity or partial invalidity of one or more provisions of this Agreement shall not invalidate any other provision of
this Agreement. No waiver by either party of any provision or condition to be performed shall be deemed a waiver of similar or dissimilar
provisions or conditions at the same time or any prior or subsequent time.

 

(e)       This
Agreement shall inure to the benefit of, be binding upon and enforceable against, the parties hereto and their respective successors,
heirs, beneficiaries and permitted assigns. The headings contained in this Agreement are for convenience of reference only and shall not
affect in any way the meaning or interpretation of this Agreement.

 

(f)       All
notices, requests, demands and other communications required or permitted to be given hereunder shall be in writing and shall be deemed
to have been duly given when personally delivered, sent by registered or certified mail, return receipt requested, postage prepaid, or
by reputable national overnight delivery service (e.g. Federal Express) for overnight delivery to the party at the address set forth in
the preamble to this Agreement, or to such other address as either party may hereafter give the other party notice of in accordance with
the provisions hereof. Notices shall be deemed given on the sooner of the date actually received or the third business day after deposited
in the mail or one business day after deposited with an overnight delivery service for overnight delivery.

 

(g)       Choice
of Law, Jurisdiction and Venue. The corporate laws of the State of New York shall govern all issues concerning this Agreement. All
other questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting the New York, New York, for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and
hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such
suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall
be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of
the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other
jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

(h)       This
Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one of the same instrument. The parties hereto have executed this Agreement as of the date set forth above.

 

    	 	7	 

    	 

    

 

(i)       The
Executive represents and warrants to the Company, that he has the full power and authority to enter into this Agreement and to perform
his obligations hereunder and that the execution and delivery of this Agreement and the performance of his obligations hereunder will
not conflict with any agreement to which Executive is a party. The Company represents and warrants to Executive that it has the full power
and authority to enter into this Agreement and to perform its obligations hereunder and that the execution and delivery of this Agreement
and the performance of its obligations hereunder will not conflict with any agreement to which the Company is a party.

 

[Signature page follows immediately]

 

    	 	8	 

    	 

    

 

IN WITNESS
WHEREOF, the Executive and the Company have caused this Executive Employment Agreement to be executed as of the date first above
written.

 

	AULT GLOBAL HOLDINGS, INC.
	 	 
	 	 
	By:	/s/ William B. Horne
	Name:	William B. Horne
	Title:	Chief Executive Officer
	 	 
	 	 
	AULT ALLIANCE, INC.
	 	 
	 	 
	By:	/s/ Darren Magot
	Name:	Darren Magot
	Title:	Chief Executive Officer
	 	 
	 	 
	EXECUTIVE
	 	 
	 	 
	By:	/s/ Christopher Wu
	Name:	Christopher Wu

 

    	 	9	 

    	 

    

 

ANNEX A

 

Overview

Provide executive leadership of business, transactional,
financing and investment development to promote sustainable growth of the Company. Work closely with CEO and Executive Chairman and the
Company’s subsidiaries and business units to build a cohesive organization that operates with an efficient, consistent approach
to investments and securities and the investor community.

 

Assist the Company and its subsidiaries and business
units to implement strategic and business development. Oversee Company-wide strategic planning process and contribute to identifying and
analyzing potential new acquisitions as well as identifying, analyzing and divesting sub-optimized business units, if any.

 

Responsibilities 

 

		-	Strategic Planning: Develop strategic investment plan to drive sustainable and profitable growth

		o	Draw input from the CEO and Executive Chairman, the business units and AGH Corporate to provide a solid
factual basis developing the strategic investment plan

		o	Identify and analyze acquisitions or investments, joint ventures and partnerships that will drive growth
profitably and value creation sustainably over time

 

		-	Business Development: Support structured business acquisition process across all business units
and implement an automated platform to manage the opportunity stream

		o	Help define criteria and processes for moving opportunities through the business acquisition funnel with
the greatest efficiency based projected prospects of success

 

		-	Communications: Support a communications plan with clear protocols to raise positive awareness
of the Company and deliver clear, compelling messages that will resonate with targeted stakeholder groups (i.e., customers, prospective
customers, investors, prospective investors, business partners, competitors, government policy holders, market analysts, the media, financial
institutions, employees, prospective employees, corporate executives and managers)

 

		-	Special Projects: Manage projects from the CEO and Executive Chairman as assigned

 

    	 		 

    	 

    

 

ANNEX B

 

CLAWBACK POLICY FOR RESTATEMENTS

 

In the event that Ault Global
Holdings, Inc. or any of its subsidiaries (including its subsidiaries, the “Corporation”) is required under Generally
Accepted Accounting Principles (“GAAP”) to prepare an accounting restatement to correct an accounting error on an interim
or annual financial statement included in a report on Form 10-Q or 10-K, due to material noncompliance with any financial reporting requirement
under the federal security laws, the Board shall determine whether the restatement was caused by the knowing misconduct of the CEO, CFO
or other Section 16 Officer:

 

(a)          If
the Board determines that knowing misconduct by any member of the Board, the CEO, the CFO or any other Section 16 officer has occurred
and caused such restatement, it shall take the steps necessary to secure reimbursement from his/her:

 

(i)       any
bonus or other incentive-based or equity-based compensation received by the responsible officer or director from the Corporation during
the 9-month period following the first public issuance or filing with the Securities and Exchange Commission (whichever occurs first)
of the financial document embodying such error; and

 

(ii)       any
net profits realized by the responsible officer or director from the sale of the Corporation’s securities during that 9-month period;
and

 

(b         If
the Board determines that the restatement was due to something other than misconduct, then the Board must recoup any excess incentive-
or performance-based compensation paid to executive officers based on overstated performance of the Corporation in order to ensure proper
alignment of compensation with actual performance and long-term value creation. The Board’s determination and bases therefor must
be recorded in the Board resolutions or minutes;

 

(c)         The
Board shall disclose in the Corporation’s proxy statement the results of its investigation into the reasons for the restatement
and the amount of incentive compensation recouped, if any, on the basis of the investigation;

 

(d)         This
provision does not purport to limit Section 304 of the Sarbanes-Oxley Act of 2002 (the “SOX”) in any way, but any monies
recovered under this provision shall be deemed by the Corporation to have been recovered under Section 304 of SOX; and

 

(e)         All
current employment agreements and contracts relating to compensation of the Corporation’s officers and directors shall be modified
to reflect this policy.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]